16.17
price up icon0.94%   0.15
after-market After Hours: 15.00 -1.17 -7.24%
loading
Fulgent Genetics Inc stock is traded at $16.17, with a volume of 433.71K. It is up +0.94% in the last 24 hours and up +9.48% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
See More
Previous Close:
$16.02
Open:
$16.03
24h Volume:
433.71K
Relative Volume:
0.87
Market Cap:
$466.42M
Revenue:
$322.67M
Net Income/Loss:
$-61.63M
P/E Ratio:
-8.2273
EPS:
-1.9654
Net Cash Flow:
$-124.21M
1W Performance:
+2.15%
1M Performance:
+9.48%
6M Performance:
-28.95%
1Y Performance:
-15.25%
1-Day Range:
Value
$16.03
$16.50
1-Week Range:
Value
$14.23
$16.50
52-Week Range:
Value
$13.46
$31.04

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name
Name
Fulgent Genetics Inc
Name
Phone
626-350-0537
Name
Address
4399 SANTA ANITA AVE, EL MONTE
Name
Employee
1,315
Name
Next Earnings Date
2025-08-01
Name
Latest SEC Filings
Name
FLGT's Discussions on Twitter

Compare FLGT vs TMO, DHR, IDXX, A, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
FLGT icon
FLGT
Fulgent Genetics Inc
16.17 462.09M 322.67M -61.63M -124.21M -1.9654
TMO icon
TMO
Thermo Fisher Scientific Inc
531.67 195.93B 44.56B 6.72B 6.29B 17.74
DHR icon
DHR
Danaher Corp
198.14 140.56B 24.57B 3.60B 5.26B 5.051
IDXX icon
IDXX
Idexx Laboratories Inc
580.76 46.39B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
119.77 34.02B 7.07B 1.29B 993.00M 4.5355
WAT icon
WAT
Waters Corp
326.20 32.49B 3.17B 642.63M 516.49M 10.77

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-25 Upgrade UBS Neutral → Buy
Dec-07-23 Initiated UBS Neutral
Dec-08-22 Downgrade Piper Sandler Overweight → Neutral
Nov-18-22 Initiated Raymond James Outperform
Aug-25-22 Initiated Credit Suisse Outperform
Feb-04-22 Resumed Piper Sandler Overweight
Aug-05-21 Resumed Credit Suisse Underperform
Jan-08-21 Downgrade Credit Suisse Neutral → Underperform
Nov-24-20 Downgrade BTIG Research Buy → Neutral
Aug-20-20 Initiated Oppenheimer Outperform
May-29-20 Initiated BTIG Research Buy
Nov-05-19 Upgrade Piper Jaffray Neutral → Overweight
Mar-01-18 Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17 Downgrade Raymond James Outperform → Mkt Perform
View All

Fulgent Genetics Inc Stock (FLGT) Latest News

pulisher
Apr 13, 2026

Stock Recap: Whats the analyst consensus on Fulgent Genetics Inc2026 Growth vs Value & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Pullback Watch: Is Fulgent Genetics Inc a momentum stock2026 Levels & Daily Momentum Trading Reports - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Stop Loss: Can Fulgent Genetics Inc stock outperform in a bear market2026 Biggest Moves & Risk Managed Investment Entry Signals - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Fulgent Genetics Inc (FLGT) Stock Down 3.9% -- Now Undervalued? GF Score: 64/100 - GuruFocus

Apr 10, 2026
pulisher
Apr 09, 2026

Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily

Apr 09, 2026
pulisher
Apr 09, 2026

Buyback Watch: What is the long term forecast for Fulgent Genetics Inc stockEarnings Trend Report & Safe Entry Trade Signal Reports - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Can Fulgent Genetics Inc stock outperform in a bear marketTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Surprises Report: Can Fulgent Genetics Inc stock outperform in a bear market2026 Action & Accurate Buy Signal Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 02, 2026

Hennion & Walsh Asset Management Inc. Makes New $1.74 Million Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat

Apr 02, 2026
pulisher
Apr 01, 2026

FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, ... - Bluefield Daily Telegraph

Apr 01, 2026
pulisher
Apr 01, 2026

FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Apr 01, 2026
pulisher
Apr 01, 2026

Dow Update: What are Fulgent Genetics Incs technical support levelsWeekly Stock Analysis & Risk Managed Investment Signals - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

Aug Volume: What is the long term forecast for Fulgent Genetics Inc stockWeekly Loss Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Apr 01, 2026
pulisher
Apr 01, 2026

FLGT PE Ratio & Valuation, Is FLGT Overvalued - Intellectia AI

Apr 01, 2026
pulisher
Apr 01, 2026

JPMorgan Chase & Co. Increases Position in Fulgent Genetics, Inc. $FLGT - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc - ACCESS Newswire

Apr 01, 2026
pulisher
Mar 31, 2026

Fulgent Genetics (NASDAQ: FLGT) CEO cancels 750,000-share prepaid forward - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Fulgent Genetics (NASDAQ: FLGT) CEO reports 30.7% ownership stake - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

[ARS] Fulgent Genetics, Inc. SEC Filing - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Fulgent Genetics (NASDAQ: FLGT) outlines 2026 meeting, pay and equity plan votes - Stock Titan

Mar 31, 2026
pulisher
Mar 30, 2026

Fulgent Genetics (FLGT) price target decreased by 27.72% to 24.82 - MSN

Mar 30, 2026
pulisher
Mar 29, 2026

Short Interest in Fulgent Genetics Rises 38.7% - National Today

Mar 29, 2026
pulisher
Mar 29, 2026

Technical Reactions to FLGT Trends in Macro Strategies - Stock Traders Daily

Mar 29, 2026
pulisher
Mar 29, 2026

Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Rises By 38.7% - MarketBeat

Mar 29, 2026
pulisher
Mar 29, 2026

Fulgent Genetics Receives 'Hold' Rating from Analysts - National Today

Mar 29, 2026
pulisher
Mar 29, 2026

Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Mar 29, 2026
pulisher
Mar 25, 2026

FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc. - lincolnjournal.com

Mar 25, 2026
pulisher
Mar 23, 2026

FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent ... - Bluefield Daily Telegraph

Mar 23, 2026
pulisher
Mar 23, 2026

Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com

Mar 23, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Fulgent Genetics (FLGT) - Stock Titan

Mar 21, 2026
pulisher
Mar 21, 2026

Aug Weekly: How is Fulgent Genetics Inc managing supply chain issues2026 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Fulgent Genetics, Inc.Common Stock (NQ: FLGT - The Chronicle-Journal

Mar 20, 2026
pulisher
Mar 19, 2026

FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - GlobeNewswire Inc.

Mar 19, 2026
pulisher
Mar 19, 2026

Fulgent Genetics Completes $56.9M Acquisition of Bako Diagnostics and StrataDx to Expand Precision Medicine Services - Minichart

Mar 19, 2026
pulisher
Mar 18, 2026

Trading the Move, Not the Narrative: (FLGT) Edition - Stock Traders Daily

Mar 18, 2026
pulisher
Mar 18, 2026

Published on: 2026-03-19 03:58:12 - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 18, 2026

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx - BioSpace

Mar 18, 2026
pulisher
Mar 18, 2026

Fulgent Genetics completes $56.9M pathology lab acquisitions By Investing.com - Investing.com Australia

Mar 18, 2026
pulisher
Mar 17, 2026

FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire

Mar 17, 2026
pulisher
Mar 17, 2026

Fulgent Genetics Acquires Bako Diagnostics Assets, StrataDx for $56.9 Million - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Fulgent Genetics completes $56.9M pathology lab acquisitions - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Fulgent Genetics Expands Dermatology Footprint With Key Acquisitions - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

Fulgent Genetics (NASDAQ: FLGT) buys Bako Diagnostics and StrataDx - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Fulgent Genetics (NASDAQ:FLGT) Stock Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm - The Globe and Mail

Mar 16, 2026
pulisher
Mar 14, 2026

Fulgent Genetics (FLGT) Stock Analysis Report | Financials & Insights - Benzinga España

Mar 14, 2026
pulisher
Mar 13, 2026

Fulgent Genetics seeks new collaborations at Copenhagen ADPD2026 event - Traders Union

Mar 13, 2026
pulisher
Mar 13, 2026

Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire

Mar 13, 2026
pulisher
Mar 12, 2026

Lowey Dannenberg, P.C. is Investigating Fulgent Genetics - GlobeNewswire

Mar 12, 2026
pulisher
Mar 12, 2026

Fulgent Genetics: A Major Market Misconception (NASDAQ:FLGT) - Seeking Alpha

Mar 12, 2026
pulisher
Mar 12, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.FLGT - PR Newswire

Mar 12, 2026

Fulgent Genetics Inc Stock (FLGT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
DGX DGX
$191.42
price down icon 1.41%
LH LH
$266.73
price down icon 0.80%
MTD MTD
$1,315.85
price down icon 1.91%
$207.19
price down icon 3.47%
IQV IQV
$178.10
price up icon 1.61%
WAT WAT
$326.20
price down icon 1.44%
Cap:     |  Volume (24h):